Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Prednisone
Related studies linked through entity extraction aliases.
Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy
- Status
- UNKNOWN
- Phase
- NA
Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating the Safety and Efficacy of C-CHOP in Untreated Subjects With Angioimmunoblastic T Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies
- Status
- RECRUITING
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Exclusive Enteral Nutrition and Corticosteroids Therapy in Crohn's Disease (EENCD)
- Status
- TERMINATED
- Phase
- PHASE4
STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Veloxis de Novo Kidney Transplant ECSWD
- Status
- UNKNOWN
- Phase
- PHASE4
Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
KPL-301 for Subjects With Giant Cell Arteritis
- Status
- COMPLETED
- Phase
- PHASE2
Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)
- Status
- COMPLETED
- Phase
- PHASE1
Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT
- Status
- TERMINATED
- Phase
- PHASE3
Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3